Zhengye Biotechnology Holding (ZYBT) Work In Process (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Work In Process of $2.5 million for Q4 2025, down 45.8% year-over-year from $4.6 million in Q4 2024, and down 45.8% quarter-over-quarter from $4.6 million in Q4 2024.
Zhengye Biotechnology Holding (ZYBT) Work In Process (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Work In Process for 3 consecutive years, with $2.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Work In Process fell 45.8% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $2.5 million (down 45.8% YoY), while the FY2025 annual figure was $2.5 million, down 44.15% from the prior year.
- Work In Process eased to $2.5 million in Q4 2025 per ZYBT's latest filing, from $4.6 million in the prior quarter.
- Across five years, Work In Process topped out at $4.7 million in Q4 2023 and bottomed at $2.5 million in Q4 2025.
- Historically, Work In Process has averaged $3.9 million across 3 years, with a median of $4.6 million in 2024.
- Annual changes were most pronounced in 2024 — Work In Process slipped 1.31% — and 2025, when it tumbled 45.8%.
- Zhengye Biotechnology Holding's Work In Process stood at $4.7 million in 2023, then slipped by 1.31% to $4.6 million in 2024, then sank by 45.8% to $2.5 million in 2025.
- Business Quant data shows ZYBT's Work In Process at $2.5 million in Q4 2025, $4.6 million in Q4 2024, and $4.7 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Zhengye Biotechnology Holding | 88.07 Mn | 80.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | 4.60 Mn |
| Dec 31, 2023 | 4.66 Mn |